Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol in Acute Respiratory Distress Syndrome (ARDS)
NCT05847517Phase 3Terminated
- Sponsor
- CiberMed
- Start
- Jul 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metoprolol in acute respiratory distress syndrome (ARDS), sponsored by CiberMed. Started Jul 2024; status: terminated.
02
Drugs
metoprolol
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05847517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05847517.